Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Topcon Maestro2 OCT Angiography Software Evaluation Study

NCT04701931 is registered in ClinicalTrials.gov with Topcon Corporation as lead sponsor.

NCT NCT04701931
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04701931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Topcon Maestro2 OCT Angiography Software Evaluation Study
Lead sponsor
Topcon Corporation
Phase
Observational
Overall status
Completed
Start date
January 7, 2021
Completion date
June 6, 2023
Enrollment
135 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

retina condition followed by fluorescein angiography imaging